{
    "data": [
        {
            "id": "6905074cecb8a7000146330d",
            "title": "How Is The Market Feeling About InterDigital Inc?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>InterDigital Inc's</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/IDCC\" target=\"_blank\">IDCC</a>) short interest as a percent of float has risen 10.71% since its last report. According to exchange reported data, there are now <strong>2.40 million shares sold short</strong>, which is 13.44% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 5.99 days to cover their short positions on average.</strong></p><!--/$--><!--$--><h3 class=\"block core-block\">Why Short Interest Matters</h3><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href=\"https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage\" target=\"_blank\">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p><!--/$--><!--$--><p class=\"block core-block\">Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p><!--/$--><!--$--><!--/$--><!--$--><div class=\"sc-jWAYhW dvGDGG\"></div><!--/$--><!--$--><h3 class=\"block core-block\">InterDigital Inc Short Interest Graph (3 Months)</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNzAwIiBoZWlnaHQ9IjUwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2ZXJzaW9uPSIxLjEiLz4=\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 700px, (min-width: 800px) 700px\" src=\"https://www.benzinga.com/files/images/story/2025/1761937229_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761937229_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=750 1x, https://www.benzinga.com/files/images/story/2025/1761937229_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">As you can see from the chart above the percentage of shares that are sold short for InterDigital Inc has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Comparing InterDigital Inc's Short Interest Against Its Peers</h3><!--/$--><!--$--><p class=\"block core-block\">Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p><!--/$--><!--$--><p class=\"block core-block\">According to <a href=\"https://www.benzinga.com/pro/\" target=\"_blank\">Benzinga Pro</a>, InterDigital Inc's peer group average for short interest as a percentage of float is 8.23%, which means the company has <strong>more</strong> short interest than most of its peers.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href=\"https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage\" target=\"_blank\"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/short-sellers/25/10/48571442/how-is-the-market-feeling-about-interdigital-inc",
            "pub_date": "2025-11-01 03:00:32",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6905074fecb8a7000146330f",
            "title": "A Look Into Kellanova Inc&#39;s Price Over Earnings",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">In the current session, the stock is trading at $83.15, after a <strong>0.02%</strong> spike. Over the past month, <strong>Kellanova Inc. (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/K\" target=\"_blank\">K</a>)</strong> stock increased by <strong>0.42%</strong>, and in the past year, by <strong>3.08%</strong>. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.</p><!--/$--><!--$--><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNjAwIiBoZWlnaHQ9IjYwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2ZXJzaW9uPSIxLjEiLz4=\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 600px, (min-width: 800px) 600px\" src=\"https://www.benzinga.com/files/images/story/2025/1761937232_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1200\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761937232_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=640 1x, https://www.benzinga.com/files/images/story/2025/1761937232_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1200 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><h3 class=\"block core-block\">Kellanova P/E Compared to Competitors</h3><!--/$--><!--$--><p class=\"block core-block\">The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. </p><!--/$--><!--$--><p class=\"block core-block\">Kellanova has a better P/E ratio of <strong>22.71</strong> than the aggregate P/E ratio of <strong>18.97</strong> of the Food Products industry. Ideally, one might believe that Kellanova Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. </p><!--/$--><!--$--><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNzAwIiBoZWlnaHQ9IjUwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2ZXJzaW9uPSIxLjEiLz4=\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 700px, (min-width: 800px) 700px\" src=\"https://www.benzinga.com/files/images/story/2025/1761937232_1.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761937232_1.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=750 1x, https://www.benzinga.com/files/images/story/2025/1761937232_1.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes. </p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48571444/a-look-into-kellanova-incs-price-over-earnings",
            "pub_date": "2025-11-01 03:00:35",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69050302ecb8a70001463137",
            "title": "Sable Stock Drops: Hunterbrook Says Key Info Was Leaked To Investors",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Sable Offshore Corp.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/SOC\" target=\"_blank\">SOC</a>) shares fell on Friday after Hunterbrook Media published a report alleging the company leaked key information to investors, including <a href=\"https://www.benzinga.com/news/25/10/48568756/markets-today-wall-street-friday-amazon-apple-first-solar-earnings-nasdaq-100-netflix-stock-split\" target=\"_blank\">golfer <strong>Phil Mickelson</strong>.</a></p><!--/$--><!--$--><p class=\"block core-block\">Here’s what to know: </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><em>SOC stock is dropping. <a href=\"https://www.benzinga.com/quote/SOC\" target=\"_blank\">See the real-time price action here. </a></em></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">According to <a href=\"https://hntrbrk.com/sable-2/\" target=\"_blank\">the report</a> from Hunterbrook, a leaked call revealed that Sable CEO <strong>Jim Flores</strong> told select investors the company might need to raise up to $200 million by the end of 2025, information not publicly disclosed. </p><!--/$--><!--$--><p class=\"block core-block\">Benzinga reached out to Sable Offshore, Mickelson and the White House and did not receive an immediate response.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">Hunterbrook alleged that the leak is part of a pattern of selective sharing with investors like Mickelson, who passed on tips in a private group chat about an upcoming SEC filing that briefly lifted Sable's stock.</p><!--/$--><!--$--><p class=\"block core-block\">Hunterbrook said that Sable later claimed the leaked recording was AI-generated. </p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\">In the call, Flores allegedly discussed seeking help from President <strong>Donald Trump</strong> and Commerce Secretary <strong>Howard Lutnick</strong> to bypass state rules and fund the project, even offering a golf round with Mickelson. </p><!--/$--><!--$--><p class=\"block core-block\">The report claims a source close to Lutnick has denied any contact, while Mickelson dismissed concerns in the group chat, joking about the group’s poor investment record.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>SOC Price Action: </strong>Sable Offshore shares were down 11.78% at $11.32 on Friday afternoon, according to data from <a href=\"https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw\" target=\"_blank\">Benzinga Pro</a>. </p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48570916\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/news/politics/25/10/48424060/trumps-white-house-ballroom-donors-include-google-micron-palantir-and-more\" target=\"_blank\"><strong>Trump’s White House Ballroom Donors Include Google, Micron, Palantir and More</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/group-chat.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/short-ideas/25/10/48570916/sable-stock-drops-hunterbrook-says-key-info-was-leaked-to-investors",
            "pub_date": "2025-11-01 02:42:23",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690503f0ecb8a700014631a1",
            "title": "Eli Lilly Seen In &#39;Pole Position&#39; For Growth, Analysts Say",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Eli Lilly and Co.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/LLY\" target=\"_blank\">LLY</a>) reported better-than-expected third-quarter earnings on Thursday and boosted its annual forecast, sending the stock higher.</p><!--/$--><!--$--><p class=\"block core-block\">The U.S. <a href=\"https://www.benzinga.com/topic/weight-loss\" rel=\"noreferrer noopener\" target=\"_blank\">weight loss drug giant</a> reported quarterly revenue of $17.60 billion, up 54% year over year, beating the consensus of $16.02 billion. This growth was driven by a 62% increase in volume, partially offset by a 10% decrease due to lower realized prices.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The company reported an adjusted earnings per share of $7.02, a sharp jump from $1.18 a year ago, <a href=\"https://www.benzinga.com/markets/earnings/25/10/48529099/mounjaro-and-zepbound-power-eli-lillys-54-revenue-jump-in-q3-hikes-2025-forecast\" rel=\"noreferrer noopener\" target=\"_blank\">beating the consensus of $5.70</a>.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Analyst Take</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Goldman Sachs </strong>on Friday wrote, \"Headed into 2026, we continue to see LLY as optimally positioned into the launch of orforglipron, which represents one of the most significant new product cycles across our entire biopharma coverage.\"</p><!--/$--><!--$--><p class=\"block core-block\">Asad Haider maintains a Buy rating and raised the price <a href=\"https://www.benzinga.com/quote/LLY/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">forecast from $879 to $951</a>.</p><!--/$--><!--$--><p class=\"block core-block\">Goldman analyst expects lumpiness in outside U.S. Mounjaro sales to continue.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\">The analyst comments that the company's implied FY25 guidance of $63.0-$63.5 billion likely bakes in some level of conservatism and implies a potential sequential step down in outside U.S. Mounjaro revenue of $3 billion from the third quarter.</p><!--/$--><!--$--><p class=\"block core-block\">Amid rising M&amp;A activity and soaring premiums for next-generation obesity assets, Eli Lilly management said the company is already well-positioned with strong programs across all key targets.</p><!--/$--><!--$--><p class=\"block core-block\">While <a href=\"https://www.benzinga.com/m-a/25/10/48533502/pfizer-blasts-novo-nordisks-9-billion-counteroffer-for-metsera-as-reckless\" rel=\"noreferrer noopener\" target=\"_blank\">rivals seek to strengthen</a> their obesity pipelines, Lilly remains focused on defending and expanding its lead.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Goldman Sachs said Lilly's broad portfolio across current and emerging obesity treatments underpins its bullish outlook on the stock.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>BofA Securities</strong> rates Eli Lilly as Buy, reflecting its outsized/durable growth potential versus peers, and the very full catalyst path at a reasonable valuation.</p><!--/$--><!--$--><p class=\"block core-block\">Analyst Tim Anderson admits several moving parts to the Eli Lilly story, and binary event risk, both near- and intermediate-term.</p><!--/$--><!--$--><p class=\"block core-block\">BofA says, \"LLY undisputably remains in pole position in obesity.\" The analyst raised the price forecast from $900 to $950.</p><!--/$--><!--$--><p class=\"block core-block\">Discussing M&amp;A and competitor dynamics, Eli Lilly told BofA that it has robust programs against many targets.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Competition is expected, but nothing so far changes confidence in Eli Lilly's portfolio. BofA adds that the company remains highly scaled and focused on innovation and execution, even as market dynamics and noise from rivals increase.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>LLY Price Action:</strong> Eli Lilly shares were up 2.39% at $864.70 at the time of publication on Friday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48571020\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/analyst-stock-ratings/reiteration/25/10/48568702/capital-one-roll-off-will-soften-mastercards-volume-growth-into-2026-analyst-warns\" rel=\"noreferrer noopener\" target=\"_blank\">Capital One Roll-Off Will Soften Mastercard's Volume Growth Into 2026, Analyst Warns</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by M7kk via Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Weight-Loss-Injection-Pen---Mounjaro-Inj.jpeg",
            "link": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48571020/eli-lilly-seen-in-pole-position-for-growth-analysts-say",
            "pub_date": "2025-11-01 02:46:11",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6905019fecb8a70001463090",
            "title": "IBM&#39;s Quantum Roadmap Sets Stage For Real Profits Before 2030",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>International Business Machines Corp.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/IBM\" target=\"_blank\">IBM</a>) spotlighted its expanding quantum computing ambitions at its Quantum Investor Day, underscoring progress toward scalable systems and commercial viability before 2030.</p><!--/$--><!--$--><p class=\"block core-block\">Executives outlined plans to integrate quantum processing units alongside traditional CPUs and GPUs, positioning IBM at the forefront of a hybrid computing era.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The company's leadership reaffirmed confidence in accelerating revenue and cash flow growth in 2026, signaling that IBM's long-term bet on quantum could soon move from research to real-world returns.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/markets/earnings/25/10/48367025/ibm-stock-slips-despite-q3-earnings-beat-raised-guidance-on-strong-ai-related-demand\" rel=\"noreferrer noopener\" target=\"_blank\">IBM Stock Slips Despite Q3 Earnings Beat, Raised Guidance On Strong AI-Related Demand</a></em></strong></p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Analysts Reaffirm Bullish Stance</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Bank of America </strong>analysts led by <strong>Wamsi Mohan</strong> <a href=\"https://www.benzinga.com/quote/IBM/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">reiterated</a> their Buy rating on IBM with a $315 price target, following the company's Quantum Investor Day.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\">The analysts said IBM executives — including Jay Gambetta, Jerry Chow, and CFO James Kavanaugh — showcased meaningful progress in quantum computing.</p><!--/$--><!--$--><p class=\"block core-block\">The analysts said they remain optimistic about IBM's ability to successfully commercialize quantum computing, expecting it to begin contributing meaningfully to the profit and loss statement before 2030.</p><!--/$--><!--$--><p class=\"block core-block\">They noted that CFO Kavanaugh is in discussions with several governments on quantum initiatives and sees an ample addressable opportunity where IBM could gain significant share, supported by its strong mainframe base.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Cloud-First Quantum Strategy</h2><!--/$--><!--$--><p class=\"block core-block\">The bank noted IBM continues to execute on a cloud-first approach for quantum, providing access through both shared infrastructure and dedicated on-premise systems, such as at the Cleveland Clinic.</p><!--/$--><!--$--><p class=\"block core-block\">IBM's five-tier pricing model, comprising Open, Pay-As-You-Go, Flex, Premium, and On-Prem, remains unchanged and is designed to broaden user access and accelerate adoption within the quantum community.</p><!--/$--><!--$--><p class=\"block core-block\">The analysts' team highlighted IBM's focus on integrating hardware and software to solidify its leadership in QC infrastructure.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">They noted that IBM is working to establish its Qiskit (Quantum Information Software Kit) as the de facto quantum software platform, comparable to <strong>NVIDIA Corporation's</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVDA\" target=\"_blank\">NVDA</a>) CUDA in AI.</p><!--/$--><!--$--><p class=\"block core-block\">According to the analysts, Qiskit already holds a commanding lead in adoption, based on the number of dependent projects and academic references compared with other quantum SDKs.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Outlook and Valuation</h2><!--/$--><!--$--><p class=\"block core-block\">The bank forecasts EPS of $11.39 in 2025, $12.14 in 2026 and $12.87 in 2027. IBM trades at 25.5x 2026E P/E and 17x EV/EBITDA, maintaining a healthy dividend yield of about 2.2%.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The team's $315 price forecast is based on 23x EV/FCF, above IBM's historical range, reflecting improving growth prospects and stronger cash flow visibility, supported by Red Hat integration.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action:</strong> IBM shares were trading lower by 1.21% to $306.30 at last check Friday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48570750\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/markets/buybacks/25/10/48569042/autonation-steps-up-capital-returns-with-new-1-billion-buyback-plan\" rel=\"noreferrer noopener\" target=\"_blank\">AutoNation Steps Up Capital Returns With New $1 Billion Buyback Plan</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by JuliusKielaitis via Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/International-Business-Machines-Corporat.jpeg",
            "link": "https://www.benzinga.com/analyst-stock-ratings/reiteration/25/10/48570750/ibms-quantum-roadmap-sets-stage-for-real-profits-before-2030",
            "pub_date": "2025-11-01 02:36:18",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}